CA
NZ
UK
AU
IND
US
IBEX Limited filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 10, 2026, covering the fiscal year ended June 30, 2026.
IBEX Limited filed a Form 8-K on September 10, 2026, disclosing two credit agreement amendments executed on September 8, 2026, and announcing the release of financial results for its fourth quarter and fiscal year ended June 30, 2026.
Palo Alto Networks, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 10, 2026, covering the fiscal year ended July 31, 2026.
A Form 4 filed on September 10, 2026, discloses that Kenneth J. Krieg, a director of Leonardo DRS, Inc. (NASDAQ:DRS), disposed of 3,700 shares of common stock on September 9, 2026, via a gift transaction at a price of $0.
Emily M. Leproust, Chief Executive Officer and Director of Twist Bioscience Corp, filed a Form 4 on September 10, 2026, disclosing the sale of common stock on September 8, 2026, in connection with the vesting of Restricted Stock Units.
Nicholas Pfeiffer, Corporate Controller of FMC Corp (NYSE:FMC), filed a Form 4 on September 10, 2026, disclosing the sale of 1,251 shares of FMC common stock on September 9, 2026.
Paula Green, SVP of Human Resources at Twist Bioscience Corp, filed a Form 4 on September 10, 2026, reporting the sale of 907 shares of common stock on September 8, 2026, to satisfy tax withholding obligations tied to the vesting of Restricted Stock Units.
Dennis Cho, Senior Vice President, Chief Legal Officer and Corporate Secretary of Twist Bioscience Corp (NASDAQ:TWST), filed a Form 4 on September 10, 2026, reporting a sale of 412 shares of common stock on September 8, 2026, to cover tax withholding obligations tied to …
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc., filed a statement of changes in beneficial ownership on September 10, 2026, reporting the sale of common stock executed the prior day under a pre-established trading plan.
Michel Lagarde, President and CEO of West Pharmaceutical Services Inc, filed a Form 4 on September 10, 2026, disclosing the acquisition of stock options and restricted stock units granted on September 8, 2026.
Please wait processing your request...